Assystem S.A. (FRA:BZ1)
48.15
0.00 (0.00%)
Last updated: Aug 1, 2025
Intra-Cellular Therapies Revenue
In the year 2024, Assystem had annual revenue of 611.30M EUR with 5.85% growth. Assystem had revenue of 310.00M in the half year ending December 31, 2024, with 23.11% growth.
Revenue
611.30M
Revenue Growth
+5.85%
P/S Ratio
1.10
Revenue / Employee
79.70K
Employees
7,740
Market Cap
669.58M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 611.30M | 33.80M | 5.85% |
Dec 31, 2023 | 577.50M | 84.00M | 17.02% |
Dec 31, 2022 | 493.50M | 48.10M | 10.80% |
Dec 31, 2021 | 445.40M | 6.60M | 1.50% |
Dec 31, 2020 | 438.80M | -58.70M | -11.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Deutsche Bank Aktiengesellschaft | 30.07B |